Cleared Traditional

ANTI-FOG DISPOSABLE IV INDUCTION COVER (K910104) - FDA 510(k) Clearance

Class I General & Plastic Surgery device.

K910104 · Central Plastic, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
99d
Days
Class 1
Risk

K910104 is an FDA 510(k) clearance for the ANTI-FOG DISPOSABLE IV INDUCTION COVER. Classified as Protector, Wound, Plastic (product code EYF), Class I - General Controls.

Submitted by Central Plastic, Inc. (Eldorado, US). The FDA issued a Cleared decision on April 12, 1991 after a review of 99 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4014 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Central Plastic, Inc. devices

Submission Details

510(k) Number K910104 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1991
Decision Date April 12, 1991
Days to Decision 99 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 115d · This submission: 99d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code EYF Protector, Wound, Plastic
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4014
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.